The Nigerian antihypertensive adherence trial: A community-based randomized trial

Adebowale Adeyemo, Bamidele O. Tayo, Amy Luke, Olugbenga Ogedegbe, Ramon Durazo-Arvizu, Richard S. Cooper

Research output: Contribution to journalArticle

Abstract

Background: Research in industrialized countries has demonstrated that a key factor limiting the control of hypertension is poor patient adherence and that the most successful interventions for long-term adherence employ multiple strategies. Very little data exist on this question in low-income countries, wherein medication-taking behavior may be less well developed. Method: We conducted a treatment adherence trial of 544 patients [mean age ∼63 years, mean blood pressure (BP) ∼168/92 mmHg] with previously untreated hypertension in urban and rural Nigeria. Eligible participants were randomized to one of two arms: clinic management only, or clinic management and home visits. Both interventions included three elements: a community based, nurse-led treatment program with physician backup; facilitation of clinic visits and health education; and the use of diuretics and a β blocker as needed. After initial diagnosis, the management protocol was implemented by a nurse with physician backup. Participants were evaluated monthly for 6 months. Results: Medication adherence was assessed with pill count and urine testing. Drop-out rates, by treatment group, ranged from 12 to 28%. Among participants who completed the 6-month trial, overall adherence was high (∼77% of participants took >98% of prescribed pills). Adherence did not differ by treatment arm, but was better at the rural than the urban site and among those with higher baseline BP. Hypertension control (BP

Original languageEnglish (US)
Pages (from-to)201-207
Number of pages7
JournalJournal of Hypertension
Volume31
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Antihypertensive Agents
Hypertension
Ambulatory Care
Nurses
Blood Pressure
Physicians
House Calls
Medication Adherence
Therapeutics
Patient Compliance
Nigeria
Health Education
Diuretics
Developed Countries
Urine
Research

Keywords

  • adherence
  • antihypertensive
  • compliance trial
  • randomized trial

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

The Nigerian antihypertensive adherence trial : A community-based randomized trial. / Adeyemo, Adebowale; Tayo, Bamidele O.; Luke, Amy; Ogedegbe, Olugbenga; Durazo-Arvizu, Ramon; Cooper, Richard S.

In: Journal of Hypertension, Vol. 31, No. 1, 01.2013, p. 201-207.

Research output: Contribution to journalArticle

Adeyemo, Adebowale ; Tayo, Bamidele O. ; Luke, Amy ; Ogedegbe, Olugbenga ; Durazo-Arvizu, Ramon ; Cooper, Richard S. / The Nigerian antihypertensive adherence trial : A community-based randomized trial. In: Journal of Hypertension. 2013 ; Vol. 31, No. 1. pp. 201-207.
@article{fc606c62907e4f4bbf3c9ef0a7d7ea6b,
title = "The Nigerian antihypertensive adherence trial: A community-based randomized trial",
abstract = "Background: Research in industrialized countries has demonstrated that a key factor limiting the control of hypertension is poor patient adherence and that the most successful interventions for long-term adherence employ multiple strategies. Very little data exist on this question in low-income countries, wherein medication-taking behavior may be less well developed. Method: We conducted a treatment adherence trial of 544 patients [mean age ∼63 years, mean blood pressure (BP) ∼168/92 mmHg] with previously untreated hypertension in urban and rural Nigeria. Eligible participants were randomized to one of two arms: clinic management only, or clinic management and home visits. Both interventions included three elements: a community based, nurse-led treatment program with physician backup; facilitation of clinic visits and health education; and the use of diuretics and a β blocker as needed. After initial diagnosis, the management protocol was implemented by a nurse with physician backup. Participants were evaluated monthly for 6 months. Results: Medication adherence was assessed with pill count and urine testing. Drop-out rates, by treatment group, ranged from 12 to 28{\%}. Among participants who completed the 6-month trial, overall adherence was high (∼77{\%} of participants took >98{\%} of prescribed pills). Adherence did not differ by treatment arm, but was better at the rural than the urban site and among those with higher baseline BP. Hypertension control (BP",
keywords = "adherence, antihypertensive, compliance trial, randomized trial",
author = "Adebowale Adeyemo and Tayo, {Bamidele O.} and Amy Luke and Olugbenga Ogedegbe and Ramon Durazo-Arvizu and Cooper, {Richard S.}",
year = "2013",
month = "1",
doi = "10.1097/HJH.0b013e32835b0842",
language = "English (US)",
volume = "31",
pages = "201--207",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - The Nigerian antihypertensive adherence trial

T2 - A community-based randomized trial

AU - Adeyemo, Adebowale

AU - Tayo, Bamidele O.

AU - Luke, Amy

AU - Ogedegbe, Olugbenga

AU - Durazo-Arvizu, Ramon

AU - Cooper, Richard S.

PY - 2013/1

Y1 - 2013/1

N2 - Background: Research in industrialized countries has demonstrated that a key factor limiting the control of hypertension is poor patient adherence and that the most successful interventions for long-term adherence employ multiple strategies. Very little data exist on this question in low-income countries, wherein medication-taking behavior may be less well developed. Method: We conducted a treatment adherence trial of 544 patients [mean age ∼63 years, mean blood pressure (BP) ∼168/92 mmHg] with previously untreated hypertension in urban and rural Nigeria. Eligible participants were randomized to one of two arms: clinic management only, or clinic management and home visits. Both interventions included three elements: a community based, nurse-led treatment program with physician backup; facilitation of clinic visits and health education; and the use of diuretics and a β blocker as needed. After initial diagnosis, the management protocol was implemented by a nurse with physician backup. Participants were evaluated monthly for 6 months. Results: Medication adherence was assessed with pill count and urine testing. Drop-out rates, by treatment group, ranged from 12 to 28%. Among participants who completed the 6-month trial, overall adherence was high (∼77% of participants took >98% of prescribed pills). Adherence did not differ by treatment arm, but was better at the rural than the urban site and among those with higher baseline BP. Hypertension control (BP

AB - Background: Research in industrialized countries has demonstrated that a key factor limiting the control of hypertension is poor patient adherence and that the most successful interventions for long-term adherence employ multiple strategies. Very little data exist on this question in low-income countries, wherein medication-taking behavior may be less well developed. Method: We conducted a treatment adherence trial of 544 patients [mean age ∼63 years, mean blood pressure (BP) ∼168/92 mmHg] with previously untreated hypertension in urban and rural Nigeria. Eligible participants were randomized to one of two arms: clinic management only, or clinic management and home visits. Both interventions included three elements: a community based, nurse-led treatment program with physician backup; facilitation of clinic visits and health education; and the use of diuretics and a β blocker as needed. After initial diagnosis, the management protocol was implemented by a nurse with physician backup. Participants were evaluated monthly for 6 months. Results: Medication adherence was assessed with pill count and urine testing. Drop-out rates, by treatment group, ranged from 12 to 28%. Among participants who completed the 6-month trial, overall adherence was high (∼77% of participants took >98% of prescribed pills). Adherence did not differ by treatment arm, but was better at the rural than the urban site and among those with higher baseline BP. Hypertension control (BP

KW - adherence

KW - antihypertensive

KW - compliance trial

KW - randomized trial

UR - http://www.scopus.com/inward/record.url?scp=84871714312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871714312&partnerID=8YFLogxK

U2 - 10.1097/HJH.0b013e32835b0842

DO - 10.1097/HJH.0b013e32835b0842

M3 - Article

VL - 31

SP - 201

EP - 207

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 1

ER -